|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.04.21 - 17:12
|
Looking Into CVS Health′s Return On Capital Employed (Benzinga)
|
|
CVS Health (NYSE:CVS) showed a loss in earnings since Q3, totaling $2.28 billion. Sales, on the other hand, increased by 3.73% to $69.55 billion during Q4. In Q3, CVS Health earned $3.04 billion and total sales reached $67.06 billion.
read more...
|
|
14.04.21 - 17:12
|
Return On Capital Employed Overview: Yum Brands (Benzinga)
|
|
Looking at Q4, Yum Brands (NYSE:YUM) earned $478.00 million, a 3.46% increase from the preceding quarter. Yum Brands also posted a total of $1.74 billion in sales, a 20.37% increase since Q3. Yum Brands earned $462.00 million, and sales totaled $1.45...
|
|
14.04.21 - 17:12
|
Return On Capital Employed Overview: Cigna (Benzinga)
|
|
Cigna (NYSE:CI) showed a loss in earnings since Q3, totaling $1.51 billion. Sales, on the other hand, increased by 2.13% to $41.67 billion during Q4. In Q3, Cigna earned $2.14 billion and total sales reached $40.80 billion.
read more...
|
|
14.04.21 - 16:57
|
Return On Capital Employed Overview: HCA Healthcare (Benzinga)
|
|
Looking at Q4, HCA Healthcare (NYSE:HCA) earned $2.45 billion, a 85.75% increase from the preceding quarter. HCA Healthcare also posted a total of $14.29 billion in sales, a 7.38% increase since Q3. In Q3, HCA Healthcare earned $1.32 billion, and tot...
|
|
14.04.21 - 16:57
|
Looking Into Cardlytics′s Return On Capital Employed (Benzinga)
|
|
Cardlytics (NASDAQ:CDLX) reported Q4 sales of $67.08 million. Earnings fell to a loss of $6.12 million, resulting in a 62.1% decrease from last quarter. In Q3, Cardlytics brought in $46.08 million in sales but lost $16.14 million in earnings.
read m...
|
|
|